Literature DB >> 22321136

Increased incidence of Mycoplasma pneumoniae infection in Norway 2011.

H Blystad1, G Ånestad, D F Vestrheim, S Madsen, K Rønning.   

Abstract

Epidemics of Mycoplasma pneumoniae have recently been reported from England and Wales and from Denmark. A similar increase in M. pneumoniae infections was noted in Norway late autumn 2011.The epidemic has resulted in shortage of erythromycin and the use of alternative antibiotics has been recommended.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22321136     DOI： 10.2807/ese.17.05.20074-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  20 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Mycoplasma pneumoniae detection causes excess antibiotic use in Norwegian general practice: a retrospective case-control study.

Authors:  Mats Foshaug; Maria Vandbakk-Rüther; Dagfinn Skaare; Nils Grude; Morten Lindbæk
Journal:  Br J Gen Pract       Date:  2015-02       Impact factor: 5.386

3.  Respiratory tract infections during the 2011 Mycoplasma pneumoniae epidemic.

Authors:  N Reinton; L Manley; T Tjade; A Moghaddam
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-25       Impact factor: 3.267

4.  A multisite SNP genotyping and macrolide susceptibility gene method for Mycoplasma pneumoniae based on MALDI-TOF MS.

Authors:  Fei Zhao; Jianzhong Zhang; Xuemei Wang; Liyong Liu; Jie Gong; Zhixiang Zhai; Lihua He; Fanliang Meng; Di Xiao
Journal:  iScience       Date:  2021-04-16

5.  Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.

Authors:  Naoyuki Miyashita; Yasuhiro Kawai; Hiroto Akaike; Kazunobu Ouchi; Toshikiyo Hayashi; Takeyuki Kurihara; Niro Okimoto
Journal:  BMC Infect Dis       Date:  2012-05-31       Impact factor: 3.090

6.  Antibiotic prescriptions and cycles of Mycoplasma pneumoniae infections in Norway: can a nationwide prescription register be used for surveillance?

Authors:  H S Blix; D F Vestrheim; V Hjellvik; D Skaare; A Christensen; M Steinbakk
Journal:  Epidemiol Infect       Date:  2014-11-12       Impact factor: 2.451

7.  Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway.

Authors:  Jan C Holter; Fredrik Müller; Ola Bjørang; Helvi H Samdal; Jon B Marthinsen; Pål A Jenum; Thor Ueland; Stig S Frøland; Pål Aukrust; Einar Husebye; Lars Heggelund
Journal:  BMC Infect Dis       Date:  2015-02-15       Impact factor: 3.090

8.  Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011-2012.

Authors:  Roger Dumke; Christiane Schnee; Mathias W Pletz; Jan Rupp; Enno Jacobs; Konrad Sachse; Gernot Rohde
Journal:  Emerg Infect Dis       Date:  2015-03       Impact factor: 6.883

9.  Multiple-locus variable-number tandem-repeat analysis of mycoplasma pneumoniae clinical specimens and proposal for amendment of MLVA nomenclature.

Authors:  Hongmei Sun; Guanhua Xue; Chao Yan; Shaoli Li; Ling Cao; Yi Yuan; Hanqing Zhao; Yanling Feng; Liqiong Wang; Zhaoyang Fan
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

10.  Mycoplasma pneumoniae infection in children is a risk factor for developing allergic diseases.

Authors:  Qing Ye; Xiao-Jun Xu; Wen-Xia Shao; Yan-Xiang Pan; Xue-Jun Chen
Journal:  ScientificWorldJournal       Date:  2014-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.